GMMMG
skeletal events in patients with breast cancer and bone metastases. NB: Ibandronate is the only oral bisphosphonate that is licensed for the prevention of SREs in advanced breast cancer and may NOT be used interchangeably with other oral bisphosphonates 6. Contraindications (please note this does not replace the SPC or BNF and should be read in ... ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.